ArticleJGH open : an open access journal of gastroenterology and hepatology2020

Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma.

Taku Shigesawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.